002030 达安基因
午间休市 08-14 11:30:00
资讯
新帖
简况
股市必读：达安基因(002030)股东户数13.3万户，较上期减少1.48%
证券之星 · 01:21
股市必读：达安基因(002030)股东户数13.3万户，较上期减少1.48%
达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%
证券之星 · 08-11 17:29
达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%
达安基因：截至2026年7月31日，公司股东总户数约为13万3千户
证券之星 · 08-11
达安基因：截至2026年7月31日，公司股东总户数约为13万3千户
股市必读：达安基因新发布《关于下属子公司取得一个医疗器械注册证的提示性公告》
证券之星 · 08-10
股市必读：达安基因新发布《关于下属子公司取得一个医疗器械注册证的提示性公告》
达安基因（002030）披露下属子公司取得甲胎蛋白测定试剂盒医疗器械注册证，8月6日股价上涨0.36%
证券之星 · 08-06
达安基因（002030）披露下属子公司取得甲胎蛋白测定试剂盒医疗器械注册证，8月6日股价上涨0.36%
达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%
证券之星 · 08-05
达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%
达安基因：截至2026年7月31日，公司股东总户数约为13万3千户
证券之星 · 08-05
达安基因：截至2026年7月31日，公司股东总户数约为13万3千户
达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%
证券之星 · 07-22
达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%
达安基因：截至2026年6月30日，公司股东总户数约为13万5千户
证券之星 · 07-22
达安基因：截至2026年6月30日，公司股东总户数约为13万5千户
达安基因（002030）披露取得乙型肝炎病毒核酸测定试剂盒医疗器械注册证，7月21日股价下跌1.91%
证券之星 · 07-21
达安基因（002030）披露取得乙型肝炎病毒核酸测定试剂盒医疗器械注册证，7月21日股价下跌1.91%
达安基因：具备基于基因测序技术的肿瘤早筛相关技术储备
证券之星 · 07-15
达安基因：具备基于基因测序技术的肿瘤早筛相关技术储备
达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%
证券之星 · 07-14
达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%
达安基因：截至2026年6月30日，公司股东总户数约为13万5千户
证券之星 · 07-14
达安基因：截至2026年6月30日，公司股东总户数约为13万5千户
达安基因获得发明专利授权：“一种嗜热栖热菌苹果酸脱氢酶重组基因及其制备方法和应用”
证券之星 · 07-11
达安基因获得发明专利授权：“一种嗜热栖热菌苹果酸脱氢酶重组基因及其制备方法和应用”
达安基因（002030）披露2026年第一次临时股东会决议公告，7月10日股价上涨3.02%
证券之星 · 07-10
达安基因（002030）披露2026年第一次临时股东会决议公告，7月10日股价上涨3.02%
达安基因（002030）披露取得肺炎衣原体/肺炎支原体核酸检测试剂盒医疗器械注册证，7月1日股价上涨3.37%
证券之星 · 07-01
达安基因（002030）披露取得肺炎衣原体/肺炎支原体核酸检测试剂盒医疗器械注册证，7月1日股价上涨3.37%
达安基因：取得肺炎衣原体/肺炎支原体核酸检测试剂盒注册证
格隆汇 · 06-30
达安基因：取得肺炎衣原体/肺炎支原体核酸检测试剂盒注册证
达安基因：公司目前生产经营一切正常
证券之星 · 06-26
达安基因：公司目前生产经营一切正常
达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%
证券之星 · 06-23
达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%
达安基因：截至2026年5月29日，公司股东总户数约为15万3千户
证券之星 · 06-23
达安基因：截至2026年5月29日，公司股东总户数约为15万3千户
加载更多
公司概况
公司名称：
广州达安基因股份有限公司
所属行业：
医药制造业
上市日期：
2004-08-09
主营业务：
广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是分子诊断试剂、生化诊断试剂、免疫诊断试剂、体外诊断仪器。
发行价格：
7.30
{"stockData":{"symbol":"002030","market":"SZ","secType":"STK","nameCN":"达安基因","latestPrice":5.72,"timestamp":1786678263000,"preClose":5.66,"halted":0,"volume":22095555,"delay":0,"changeRate":0.0106,"floatShares":1403000000,"shares":1403000000,"eps":-0.6381,"marketStatus":"午间休市","change":0.06,"latestTime":"08-14 11:30:00","open":5.66,"high":5.82,"low":5.58,"amount":127000000,"amplitude":0.0424,"askPrice":5.72,"askSize":528,"bidPrice":5.71,"bidSize":237,"shortable":0,"etf":0,"ttmEps":-0.6381,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786683600000},"marketStatusCode":3,"adr":0,"adjPreClose":5.66,"symbolType":"stock","openAndCloseTimeList":[[1786671000000,1786678200000],[1786683600000,1786690800000]],"highLimit":6.23,"lowLimit":5.09,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1403446032,"isCdr":false,"pbRate":1.13,"roa":"--","roe":"--","epsLYR":-0.53,"committee":0.157151,"marketValue":8028000000,"turnoverRate":0.0157,"status":0,"floatMarketCap":8028000000},"requestUrl":"/m/hq/s/002030/","defaultTab":"news","newsList":[{"id":"2659169460","title":"股市必读：达安基因(002030)股东户数13.3万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659169460","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659169460?lang=zh_cn&edition=full","pubTime":"2026-08-14 01:21","pubTimestamp":1786641678,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，达安基因报收于5.66元，上涨0.35%，换手率1.89%，成交量26.52万手，成交额1.5亿元。当日关注点交易信息汇总：8月13日主力资金净流入950.35万元，占总成交额6.33%。股本股东变化股东户数变动截至2026年7月31日，达安基因股东户数为13.3万户，较6月30日减少2000户，减幅1.48%；户均持股数量由1.04万股增至1.06万股，户均持股市值为5.75万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400000912.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK0239","BK0168","BK0046","002030","BK0028","BK0122","BK0042","BK0159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658996145","title":"达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658996145","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658996145?lang=zh_cn&edition=full","pubTime":"2026-08-11 17:29","pubTimestamp":1786440575,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年7月31日公司股东户数为13.3万户，较6月30日减少2000.0户，减幅为1.48%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至7月31日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年6月30日至2026年7月31日，达安基因区间涨幅为8.13%，在此期间股东户数减少2000.0户，减幅为1.48%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100028019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0122","BK0046","BK0188","BK0042","BK0239","BK0159","002030","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658963252","title":"达安基因：截至2026年7月31日，公司股东总户数约为13万3千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2658963252","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658963252?lang=zh_cn&edition=full","pubTime":"2026-08-11 09:15","pubTimestamp":1786410919,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)08月10日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司2026年7月31日A股股东人数是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。截至2026年7月31日，公司股东总户数约为13万3千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100007302.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0028","BK0188","BK0239","BK0159","BK0042","BK0122","BK0046","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658608374","title":"股市必读：达安基因新发布《关于下属子公司取得一个医疗器械注册证的提示性公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2658608374","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658608374?lang=zh_cn&edition=full","pubTime":"2026-08-10 02:32","pubTimestamp":1786300333,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，达安基因报收于5.61元，上涨0.72%，换手率1.83%，成交量25.68万手，成交额1.42亿元。公司公告汇总关于下属子公司取得一个医疗器械注册证的提示性公告广州达安基因股份有限公司下属全资子公司广州达泰生物工程技术有限公司近日取得国家药品监督管理局颁发的医疗器械注册证，产品为甲胎蛋白测定试剂盒，注册证编号：国械注准20263401671，有效期至2031年8月3日。目前该产品尚处于市场开发阶段，市场需求存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000001091.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0188","BK1583","09996","BK0239","BK0042","BK1100","BK0168","BK1574","BK0122","002030","BK0028","BK0159","159883","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657630045","title":"达安基因（002030）披露下属子公司取得甲胎蛋白测定试剂盒医疗器械注册证，8月6日股价上涨0.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657630045","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657630045?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:30","pubTimestamp":1786026636,"startTime":"0","endTime":"0","summary":"截至2026年8月6日收盘，达安基因报收于5.57元，较前一交易日上涨0.36%，最新总市值为78.17亿元。该股当日开盘5.68元，最高5.77元，最低5.52元，成交额达1.69亿元，换手率为2.15%。近日，广州达安基因股份有限公司下属全资子公司广州达泰生物工程技术有限公司取得国家药品监督管理局颁发的医疗器械注册证，产品为甲胎蛋白测定试剂盒，注册证编号：国械注准20263401671，有效期至2031年8月3日。目前该产品尚处于市场开发阶段，市场需求存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600040019.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002030","BK1100","09996","BK0168","BK0028","BK1583","BK0042","BK0046","BK0159","BK0188","159883","BK0122","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657517293","title":"达安基因(002030)7月31日股东户数13.3万户，较上期减少1.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657517293","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657517293?lang=zh_cn&edition=full","pubTime":"2026-08-05 17:43","pubTimestamp":1785923032,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年7月31日公司股东户数为13.3万户，较6月30日减少2000.0户，减幅为1.48%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至7月31日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年6月30日至2026年7月31日，达安基因区间涨幅为8.13%，在此期间股东户数减少2000.0户，减幅为1.48%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500032424.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0168","BK0042","BK0046","BK0188","BK0028","BK0239","BK0159","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657596635","title":"达安基因：截至2026年7月31日，公司股东总户数约为13万3千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2657596635","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657596635?lang=zh_cn&edition=full","pubTime":"2026-08-05 09:06","pubTimestamp":1785891966,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至7月30日公司股东人数是多少？达安基因回复：投资者您好，感谢您对达安基因的关注。截至2026年7月31日，公司股东总户数约为13万3千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500009862.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002030","BK0122","BK0168","BK0046","BK0042","BK0239","BK0188","BK0159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653375644","title":"达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653375644","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653375644?lang=zh_cn&edition=full","pubTime":"2026-07-22 17:44","pubTimestamp":1784713467,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年6月30日公司股东户数为13.5万户，较5月29日减少1.8万户，减幅为11.76%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年5月29日至2026年6月30日，达安基因区间跌幅为28.81%，在此期间股东户数减少1.8万户，减幅为11.76%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200036442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0042","BK0239","002030","BK0188","BK0046","BK0159","BK0168","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653737063","title":"达安基因：截至2026年6月30日，公司股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653737063","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653737063?lang=zh_cn&edition=full","pubTime":"2026-07-22 15:36","pubTimestamp":1784705773,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)07月21日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至7月20日公司股东人数是多少？达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年6月30日，公司股东总户数约为13万5千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200027250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0046","BK0188","002030","BK0168","BK0159","BK0042","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653051602","title":"达安基因（002030）披露取得乙型肝炎病毒核酸测定试剂盒医疗器械注册证，7月21日股价下跌1.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653051602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653051602?lang=zh_cn&edition=full","pubTime":"2026-07-21 22:28","pubTimestamp":1784644114,"startTime":"0","endTime":"0","summary":"截至2026年7月21日收盘，达安基因报收于5.13元，较前一交易日下跌1.91%，最新总市值为72亿元。该股当日开盘5.2元，最高5.23元，最低5.03元，成交额达1.1亿元，换手率为1.54%。近日，广州达安基因股份有限公司取得国家药品监督管理局颁发的医疗器械注册证，产品名为乙型肝炎病毒核酸测定试剂盒，注册证编号国械注准20263401474，有效期至2031年7月15日。该产品用于体外定量检测人血清或血浆样本中乙型肝炎病毒脱氧核糖核酸的含量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100044914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0159","BK1583","09996","BK1574","BK0122","002030","BK0188","BK0046","BK0168","BK0239","BK1100","BK0042","159883","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651436506","title":"达安基因：具备基于基因测序技术的肿瘤早筛相关技术储备","url":"https://stock-news.laohu8.com/highlight/detail?id=2651436506","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651436506?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:37","pubTimestamp":1784086646,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)07月14日在投资者关系平台上答复投资者关心的问题。投资者提问：患癌的人群不少，公司有没有什么产品，能够提前检测提示癌症风险？达安基因回复：投资者您好，感谢您对达安基因的关注。公司具备基于基因测序技术的肿瘤早筛相关技术储备，目前针对不同癌种的早期筛查检测产品处于积极探索和研究阶段。另外，公司生免平台已有相关肿瘤标志物检测产品，可用于肿瘤的辅助诊断、诊断和治疗监测。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500019200.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0159","BK0168","BK0028","BK0188","BK0046","BK0122","002030","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651179699","title":"达安基因(002030)6月30日股东户数13.5万户，较上期减少11.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651179699","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651179699?lang=zh_cn&edition=full","pubTime":"2026-07-14 17:27","pubTimestamp":1784021278,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年6月30日公司股东户数为13.5万户，较5月29日减少1.8万户，减幅为11.76%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至6月30日，医疗器械行业平均股东户数为2.14万户。从股价来看，2026年5月29日至2026年6月30日，达安基因区间跌幅为28.81%，在此期间股东户数减少1.8万户，减幅为11.76%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400033525.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","BK0239","BK0028","BK0046","BK0122","BK0188","BK0168","BK0159","002030"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651128347","title":"达安基因：截至2026年6月30日，公司股东总户数约为13万5千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651128347","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651128347?lang=zh_cn&edition=full","pubTime":"2026-07-14 08:37","pubTimestamp":1783989428,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)07月13日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至7月10日公司股东人数是多少？达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年6月30日，公司股东总户数约为13万5千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071400008382.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0188","BK0168","BK0046","BK0239","BK0042","BK0159","002030","BK0122"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650324631","title":"达安基因获得发明专利授权：“一种嗜热栖热菌苹果酸脱氢酶重组基因及其制备方法和应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2650324631","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650324631?lang=zh_cn&edition=full","pubTime":"2026-07-11 03:52","pubTimestamp":1783713149,"startTime":"0","endTime":"0","summary":"证券之星消息，根据天眼查APP数据显示达安基因新获得一项发明专利授权，专利名为“一种嗜热栖热菌苹果酸脱氢酶重组基因及其制备方法和应用”，专利申请号为CN202210187426.7，授权日为2026年7月10日。本申请表达的苹果酸脱氢酶产量高、生产周期短以及活性高。今年以来达安基因新获得专利授权14个，较去年同期增加了366.67%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071100002933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0168","BK0159","BK0046","BK0028","BK0042","BK0122","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650877136","title":"达安基因（002030）披露2026年第一次临时股东会决议公告，7月10日股价上涨3.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2650877136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2650877136?lang=zh_cn&edition=full","pubTime":"2026-07-10 22:36","pubTimestamp":1783694173,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，达安基因报收于5.11元，较前一交易日上涨3.02%，最新总市值为71.72亿元。近日，达安基因发布《2026年第一次临时股东会决议公告》。公告显示，公司于2026年7月10日召开2026年第一次临时股东会，会议以现场投票与网络投票相结合的方式进行。出席会议的股东及授权代表共876人，代表股份471,051,330股，占公司总股份的33.5639%。两项议案均获得出席会议有表决权股份总数的二分之一以上同意，表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000044744.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0042","BK0239","002030","BK0028","BK0122","BK0046","BK0188","BK0159"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511193","title":"达安基因（002030）披露取得肺炎衣原体/肺炎支原体核酸检测试剂盒医疗器械注册证，7月1日股价上涨3.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511193","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648511193?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:48","pubTimestamp":1782899306,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，达安基因报收于5.21元，较前一交易日上涨3.37%，最新总市值为73.12亿元。该股当日开盘5.01元，最高5.21元，最低4.97元，成交额达1.22亿元，换手率为1.69%。达安基因于近日取得国家药品监督管理局颁发的医疗器械注册证，产品名称为肺炎衣原体/肺炎支原体核酸检测试剂盒，注册证编号国械注准20263401391，有效期至2031年6月29日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034574.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0122","002030","BK1100","BK0159","159883","BK0239","BK1583","BK0042","BK0028","BK0046","BK0168","BK0188","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647536628","title":"达安基因：取得肺炎衣原体/肺炎支原体核酸检测试剂盒注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2647536628","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2647536628?lang=zh_cn&edition=full","pubTime":"2026-06-30 16:44","pubTimestamp":1782809057,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["002030","BK0168","BK0159","BK0046","BK0028","BK0042","BK0122","BK0188","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646387567","title":"达安基因：公司目前生产经营一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2646387567","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2646387567?lang=zh_cn&edition=full","pubTime":"2026-06-26 08:57","pubTimestamp":1782435428,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因06月25日在投资者关系平台上答复投资者关心的问题。公司目前生产经营一切正常，各项业务有序开展，无重大经营风险。截至2025年12月31日，公司净资产约为71.38亿元，不存在资不抵债情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600007659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002030","BK0028","BK0042","BK0122","BK0239","BK0046","BK0159","BK0168","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645882404","title":"达安基因(002030)5月29日股东户数15.3万户，较上期增加13.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645882404","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645882404?lang=zh_cn&edition=full","pubTime":"2026-06-23 17:41","pubTimestamp":1782207692,"startTime":"0","endTime":"0","summary":"证券之星消息，近日达安基因披露，截至2026年5月29日公司股东户数为15.3万户，较4月30日增加1.8万户，增幅为13.33%。在医疗器械行业个股中，达安基因股东户数高于行业平均水平，截至5月29日，医疗器械行业平均股东户数为2.21万户。从股价来看，2026年4月30日至2026年5月29日，达安基因区间涨幅为22.49%，在此期间股东户数增加1.8万户，增幅为13.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300030503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","BK0042","BK0159","002030","BK0188","BK0046","BK0122","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645988931","title":"达安基因：截至2026年5月29日，公司股东总户数约为15万3千户","url":"https://stock-news.laohu8.com/highlight/detail?id=2645988931","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2645988931?lang=zh_cn&edition=full","pubTime":"2026-06-23 15:57","pubTimestamp":1782201429,"startTime":"0","endTime":"0","summary":"证券之星消息，达安基因(002030)06月23日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问截至6月18日公司的股东是多少？谢谢达安基因回复：投资者您好，感谢您对达安基因的关注。公司仅提供每月月末股东人数，截至2026年5月29日，公司股东总户数约为15万3千户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300024272.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0042","002030","BK0159","BK0239","BK0046","BK0188","BK0028","BK0122","BK0168"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786678317924,"stockEarnings":[{"period":"1week","weight":0.0162},{"period":"1month","weight":0.0864},{"period":"3month","weight":-0.0629},{"period":"6month","weight":-0.1016},{"period":"1year","weight":-0.1983},{"period":"ytd","weight":-0.0503}],"compareEarnings":[{"period":"1week","weight":0.0068},{"period":"1month","weight":-0.0101},{"period":"3month","weight":-0.0504},{"period":"6month","weight":-0.038},{"period":"1year","weight":0.0661},{"period":"ytd","weight":-0.0106}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广州达安基因股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"133000人(较上一季度减少1.48%)","perCapita":"41579股","listingDate":"2004-08-09","address":"广东省广州市黄埔区高新技术开发区科学城香山路19号","registeredCapital":"140344万元","survey":" 广州达安基因股份有限公司的主营业务是以分子诊断技术为主导的，集临床检验试剂、仪器和配套耗材的研发、生产、销售。公司的主要产品是分子诊断试剂、生化诊断试剂、免疫诊断试剂、体外诊断仪器。","listedPrice":7.3},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"达安基因,002030,达安基因股票,达安基因股票老虎,达安基因股票老虎国际,达安基因行情,达安基因股票行情,达安基因股价,达安基因股市,达安基因股票价格,达安基因股票交易,达安基因股票购买,达安基因股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"达安基因(002030)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供达安基因(002030)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}